Ramires J A, Mansur A de P, César L A, Piegas L S, Timerman A, Nonohay N C, Azevedo A R, Vaz R, da Luz P L
Instituto do Coração do Hospital das Clínicas-FMUSP.
Arq Bras Cardiol. 1992 Jan;58(1):69-73.
To evaluate the effects of diltiazem and propranolol in patients with unstable angina.
Fifty-six patients with unstable angina, mean age of 55.4 +/- 8.5, 41 men and 15 women, were evaluated in a randomized, double-blind study of two groups of patients treated with diltiazem or propranolol at total daily doses of 180 mg and 120 mg respectively during the first 48 hours. After that the total daily doses was adjusted to 240 mg and 160 mg, respectively, until the 7th day. The first 48 hours, four times daily, clinical evaluation, CKMB data, ECG were obtained and two times daily until 7th day. A coronary arteriography was done on study entry.
A significative reduction of angina crisis number, duration, intensity and the number of sublingual nitrates doses were observed equally in both groups. The SAP, DAP, HR and RR did not show statistical differences between groups. Individual groups analysis showed significative reductions of SAP, DAP and HR in propranolol group. The CKMB data, ECG alterations and coronary arteriography characteristics were similar.
Both drugs were effective for the unstable angina treatment.
评估地尔硫䓬和普萘洛尔对不稳定型心绞痛患者的疗效。
56例不稳定型心绞痛患者,平均年龄55.4±8.5岁,男性41例,女性15例,在一项随机双盲研究中,两组患者在前48小时分别接受地尔硫䓬或普萘洛尔治疗,每日总剂量分别为180毫克和120毫克。此后,每日总剂量分别调整至240毫克和160毫克,直至第7天。在前48小时,每天进行4次临床评估、获取肌酸激酶同工酶(CKMB)数据和心电图,直至第7天每天进行2次。研究开始时进行冠状动脉造影。
两组患者的心绞痛发作次数、持续时间、强度和舌下含服硝酸酯类药物的剂量均有显著减少。收缩压(SAP)、舒张压(DAP)、心率(HR)和呼吸频率(RR)在两组之间无统计学差异。单个组分析显示普萘洛尔组的SAP、DAP和HR有显著降低。CKMB数据、心电图改变和冠状动脉造影特征相似。
两种药物对不稳定型心绞痛均有效。